Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Free Cash Flow (2023 - 2025)

Incannex Healthcare's Free Cash Flow history spans 3 years, with the latest figure at -$4.6 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 17.52% year-over-year to -$4.6 million; the TTM value through Dec 2025 reached -$18.4 million, down 16.21%, while the annual FY2025 figure was -$12.5 million, 22.42% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$4.6 million at Incannex Healthcare, up from -$9.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.5 million in Q2 2025 and bottomed at -$9.2 million in Q3 2025.
  • The 3-year median for Free Cash Flow is -$4.0 million (2024), against an average of -$4.2 million.
  • The largest annual shift saw Free Cash Flow soared 62.4% in 2024 before it tumbled 308.24% in 2025.
  • A 3-year view of Free Cash Flow shows it stood at -$2.2 million in 2023, then crashed by 160.27% to -$5.6 million in 2024, then grew by 17.52% to -$4.6 million in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Free Cash Flow are -$4.6 million (Q4 2025), -$9.2 million (Q3 2025), and -$1.5 million (Q2 2025).